Central India Cancer Research Institute
Nagpur, Maharashtra, India
Research institute in Nagpur, Maharashtra
11, W High Ct Rd, Shankar Nagar, East Shankar Nagar, Nagpur, Maharashtra 440010
About Central India Cancer Research Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Piramal Enterprises Limited
3
Boehringer Ingelheim
2
Exelixis
1
Janssen Research & Development, LLC
1
Pfizer
1
Puma Biotechnology, Inc.
1
Clinical Trials at Central India Cancer Research Institute
During the past decade, Central India Cancer Research Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
2009-04-29
2012-02-07
Completed
59
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
2008-06-01
2020-09-01
Completed
330
A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer
2008-09-01
2013-06-01
Completed
86
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
2009-08-21
2018-06-28
Completed
479
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
2010-06-22
2018-07-06
Completed
508
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
2011-05-24
2017-03-13
Completed
74
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
2012-09-01
2016-03-01
Suspended
60
Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors
2012-12-01
2014-12-01
Suspended
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Central India Cancer Research Institute" #1 sponsor was "Piramal Enterprises Limited" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Exelixis" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Central India Cancer Research Institute
According to Clinical.Site data, the most researched conditions in "Central India Cancer Research Institute" are
"Advanced Refractory Solid Tumors" (2 trials), "Breast Neoplasms" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Central India Cancer Research Institute" in a lesser frequency.
Clinical Trials Intervention Types at Central India Cancer Research Institute
Most popular intervention types in "Central India Cancer Research Institute" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Afatinib 40mg once daily (OD)" (1 trials), "Amivantamab" (1 trials), "BIBW 2992" (1 trials), "Carboplatin" (1 trials) and "IV Placebo for tanezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Central India Cancer Research Institute
The vast majority of trials in "Central India Cancer Research Institute" are
6 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Central India Cancer Research Institute
Currently, there are NaN active trials in "Central India Cancer Research Institute".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Central India Cancer Research Institute,
2 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Central India Cancer Research Institute, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".